Suppr超能文献

6至10月龄水牛(水牛属)中四种剂量布鲁氏菌流产RB51菌株的血清学反应、生物安全性及清除情况

Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis).

作者信息

Diptee M D, Adesiyun A A, Asgarali Z, Campbell M, Adone R

机构信息

Faculty of Medical Sciences, School of Veterinary Medicine, University of the West Indies, Champs Fleurs, Trinidad and Tobago.

出版信息

Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):43-55. doi: 10.1016/j.vetimm.2005.07.020. Epub 2005 Aug 19.

Abstract

Thirty water buffalo were obtained from a brucellosis-free farm in order to evaluate antibody responses, bacterial clearance and safety to Brucella abortus strain RB51 vaccine in a dose response study. The animals were randomly divided into five treatment groups. Groups I-V received the recommended dose of RB51 vaccine (RD) once, RD twice 4 weeks apart, double RD once, double RD twice 4 weeks apart and saline once, respectively. Antibody responses to RB51 were monitored at 2, 4, 6, 8, 10, 12, 16 18, 22, 24 and 27 post-initial-inoculation weeks (PIW). Clearance of RB51 from the prescapular lymph node was evaluated at 2, 4, 6, 12, 18 and 24 PIW for groups 1, III and V and at 6, 8, 10, 16, 22 and 27 PIW for groups II and IV. To evaluate shedding of the RB51 strain, nasal, conjunctival, vaginal or preputial swabs were taken from all experimental animals at 1, 2, 3, 4, 6, 8 and 12 PIW. Sera taken at all PIW were negative for field strain B. abortus by both the buffered plate agglutination test (BPAT) and competitive enzyme-linked immunosorbent assay (c-ELISA). Antibody responses to RB51 were demonstrated in all vaccinates but not in the controls, up to 12 PIW, by complement fixation test (CFT) and the dot-blot assay with an 83.7% agreement for both tests. Clearance of RB51 occurred between 6 and 12 PIW in group I but less than 2 weeks after booster vaccinations in groups II and IV and between 4 and 6 PIW in group III. RB51 was not recovered at any time from swabs obtained from either RB51-vaccinates or non-vaccinates. The results of this study indicate that serologic responses to RB51 vaccination can be monitored by both CFT and dot-blot assay in water buffalo. Our data also indicates that RB51 vaccination does not interfere with brucellosis sero-surveillance and is safe (no serological and bacteriological evidence of spread to non-vaccinates, no adverse clinical signs or detectable abnormalities on haematology and serum biochemistry) for use in water buffalo.

摘要

从一个无布鲁氏菌病的农场获取了30头水牛,以便在一项剂量反应研究中评估其对布鲁氏菌流产菌株RB51疫苗的抗体反应、细菌清除情况和安全性。这些动物被随机分为五个治疗组。第一组至第五组分别接受一次推荐剂量的RB51疫苗(RD)、间隔4周接种两次RD、一次双倍剂量的RD、间隔4周接种两次双倍剂量的RD以及一次生理盐水注射。在初次接种后的第2、4、6、8、10、12、16、18、22、24和27周(PIW)监测对RB51的抗体反应。对于第一组、第三组和第五组,在PIW的第2、4、6、12、18和24周评估肩胛前淋巴结中RB51的清除情况;对于第二组和第四组,在PIW的第6、8、10、16、22和27周评估。为了评估RB51菌株的排出情况,在PIW的第1、2、3、4、6、8和12周从所有实验动物采集鼻拭子、结膜拭子、阴道拭子或包皮拭子。在所有PIW采集的血清通过缓冲平板凝集试验(BPAT)和竞争酶联免疫吸附测定(c-ELISA)检测,对野生型流产布鲁氏菌均为阴性。通过补体结合试验(CFT)和斑点印迹试验,在所有接种疫苗的动物中均检测到对RB51的抗体反应,而对照组未检测到,直至12 PIW,两种试验的一致性为83.7%。第一组中RB51在6至12 PIW之间清除,而第二组和第四组在加强接种后不到2周清除,第三组在4至6 PIW之间清除。从接种RB51疫苗的动物或未接种疫苗的动物采集的拭子中,在任何时候都未检测到RB51。本研究结果表明,在水牛中,CFT和斑点印迹试验均可用于监测对RB51疫苗接种的血清学反应。我们的数据还表明,RB51疫苗接种不会干扰布鲁氏菌病血清学监测,并且用于水牛是安全的(没有血清学和细菌学证据表明传播至未接种疫苗的动物,没有不良临床症状,血液学和血清生化检查未发现可检测到的异常)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验